Ilkka Julkunen - UTU Research Portal

Ilkka Julkunen

- ,
InFLAMES Flagship (Faculty of Medicine)
- Senior Advisor,
Institute of Biomedicine (Faculty of Medicine)

ilkka.julkunen@utu.fi

+358 29 450 4507

+358 50 449 9721

Kiinamyllynkatu 10

Turku

Publications

1 of 12

Nucleocapsid protein enhances spike- and RBD-specific humoral and cellular immune responses in protein-based SARS-CoV-2 vaccine (2026)
- BMC Infectious Diseases
Gröhn, Stina; Lehto, Heini; Soppela, Saana; Naves, Rauno A.; Ritvos, Mikael A.; Iakubovskaia, Alina; Lampinen, Vili; Mustonen, Iiris; Pakkala, Sanniina; Husu, Elizaveta; Kakkola, Laura; Julkunen, Ilkka; Kolehmainen, Pekka; Pasternack, Arja; Ritvos, Olli; Hankaniemi, Minna M.
(A1 Refereed original research article in a scientific journal)
SARS-CoV-2 seroprevalence and seroconversion in Finnish households with school-aged children between June 2020 and April 2022 (2026)
- Infectious Diseases
Ahti, Jaakko; Ollila, Helena; Toivonen, Laura; Salo-Tuominen, Krista; Ivaska, Lauri; Julkunen, Ilkka; Peltola, Ville
(A1 Refereed original research article in a scientific journal)
COVID-19 vaccine type controls stromal reprogramming in draining lymph nodes (2025)
- Science Immunology
Fair-Mäkelä, Ruth; Thorén, Pinja; Näsiaho, Joni; Sundqvist, Pia; Piiroinen, Irina; Kähäri, Laura; Julkunen, Ilkka; Ivaska, Johanna; Hub, Elin; Rot, Antal; Ghimire, Bishwa; Alanko, Jonna; Salmi, Marko
(A1 Refereed original research article in a scientific journal)
Glucose Metabolism and Innate Immune Responses in Influenza Virus Infection: Mechanistic Insights and Clinical Perspectives (2025)
- Cells
Awad, Kareem; Shahin, Nancy N.; Motawi, Tarek K.; Abdelhadi, Maha; Barghash, Reham F.; Awad, Ahmed M.; Kakkola, Laura; Julkunen, Ilkka
(A2 Refereed review article in a scientific journal )
HCoV-229E does not trigger early interferon gene expression and evades IFN signaling in human A549 lung epithelial cells (2025)
- Microbiology spectrum
Lundberg, Rickard; Jartti, Anna; Heroum, Jemna; Kakkola, Laura; Julkunen, Ilkka
(A1 Refereed original research article in a scientific journal)
Highly Pathogenic Avian Influenza (HPAI) H5N1 virus in Finland in 2021–2023 – Genetic diversity of the viruses and infection kinetics in human dendritic cells (2025)
- Emerging microbes & infections
Altan, Eda; Avelin, Veera; Aaltonen, Kirsi; Korhonen, Essi; Laine, Larissa; Lindh, Erika; Julkunen, Ilkka; Tammiranta, Niina; Nokireki, Tiina; Gadd, Tuija; Kakkola, Laura; Sironen, Tarja; Österlund, Pamela
(A1 Refereed original research article in a scientific journal)
Influenza A(H5N8) vaccine induces humoral and cell-mediated immunity against highly pathogenic avian influenza clade 2.3.4.4b A(H5N1) viruses in at-risk individuals (2025)
- Nature Microbiology
Liedes, Oona; Reinholm, Arttu; Ekström, Nina; Haveri, Anu; Solastie, Anna; Vara, Saimi; Rijnink, Willemijn F.; Bestebroer, Theo M.; Richard, Mathilde; de Vries, Rory D.; Jalkanen, Pinja; Lindh, Erika; Ikonen, Niina; Grifoni, Alba; Sette, Alessandro; Laaksonen, Terhi; Holopainen, Riikka; Kakkola, Laura; Lappalainen, Maija; Syrjänen, Ritva K.; Kolehmainen, Pekka; Julkunen, Ilkka; Nohynek, Hanna; Melin, Merit
(A1 Refereed original research article in a scientific journal)
Long-term neutralization capacity of vaccine and breakthrough infection induced SARS-CoV-2 specific antibodies against omicron subvariants BA.2, XBB.1.5, and JN.1 (2025)
- Vaccine
Reinholm, Arttu; Khan, Hira; Laakso, Terhi; Maljanen, Sari; Jalkanen, Pinja; Gunell, Marianne; Kallonen, Teemu; Österlund, Pamela; Ritvos, Olli; Nousiainen, Arttu; Häkkinen, Hanni K.; Pakkanen, Sari H.; Välimaa, Hanna; Kantele, Anu; Lempainen, Johanna; Julkunen, Ilkka; Kolehmainen, Pekka; Kakkola, Laura
(A1 Refereed original research article in a scientific journal)
Post-COVID-19 condition in prospective inpatient and outpatient cohorts (2025)
- Scientific Reports
Hurme, Antti; Viinanen, Arja; Teräsjärvi, Johanna; Jalkanen, Pinja; Feuth, Thijs; Löyttyniemi, Eliisa; Vuorinen, Tytti; Kantele, Anu; Oksi, Jarmo; He, Qiushui; Julkunen, Ilkka
(A1 Refereed original research article in a scientific journal)
The COVID-19 vaccine ChAdOx1 is opsonized by anti-vector antibodies that activate complement and promote viral vector phagocytosis (2025)
- Scandinavian Journal of Immunology
Nissilä, Eija; Starck, Leo; Aho, Elias; Venerandi, Erika; Jalkanen, Pinja; Leskinen, Katarzyna; Uvarov, Pavel; Saavalainen, Päivi; Julkunen, Ilkka; Kotimaa, Juha; Haapasalo, Karita; Meri, Seppo
(A1 Refereed original research article in a scientific journal)